Comorbidities Clinical Trial
Official title:
Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms - IESA-Study
Patients with intracerebral aneurysm will be screened for sleep apnea using out of center polysomnography/polygraphy. Baseline blood pressure and medication will be assessed. Patients will be followed for up to 5 years to examine the increase in aneurysm size, rupture rate and changes in medication.
Patient presenting to the outpatient center for neurological of neurosurgical management of intracerebral aneurysm will be recruited. Sleep apnea will be assessed by questionnaire and out of center polygraph/polysomnography. Medication, comorbidities and blood pressure will be recorded. Change in aneurysm size and blood pressure medication will be evaluated annually for up to 5 years. Frequency of subarachnoid hemorrhage and increase in aneurysm size will be assessed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03434626 -
Advance Care Planning & Goals of Care Randomized Controlled Trial in Primary Care
|
N/A | |
| Completed |
NCT05345626 -
Vital Signs Monitoring in Rehabilitation Center Patients
|
||
| Completed |
NCT04409197 -
Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network
|
||
| Recruiting |
NCT04748770 -
Access to Kidney Transplant of Obese Patients Beginning Dialysis
|
||
| Active, not recruiting |
NCT04087239 -
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
|
||
| Completed |
NCT04109001 -
Method of Measuring Comorbidity to Predict Outcome After Intensive Care
|
||
| Completed |
NCT03348449 -
Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)
|